Insider trading

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,041 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,041 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,041 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,041 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,041 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,041 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,041 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2026
REED ELIZABETH E Chief Legal Officer and GC
Sold on a plan
$280.86K 10,000 at 28.09
8.7%
Planned (10b5-1)
16 Mar 2026
SMOLYANSKY EDWARD 10% owner
Sold at will
$274.68K 13,334 at 20.60
1.2%
Not planned
16 Mar 2026
Corrigan Catherine President & CEO
Sold on a plan 2×
$264.01K 3,912 at 67.49
3.7%
Planned (10b5-1)
16 Mar 2026
READ RORY P President & CEO
Sold at will
$263.26K 45,001 at 5.85
1.2%
Not planned
16 Mar 2026
Bell Michael Brian Chief Financial Officer
Sold at will
$261.11K 3,000 at 87.04
6.4%
Not planned
16 Mar 2026
Xia Howard H. Director
Sold at will
$258.00K 1,000 at 258.00
1.9%
Not planned
16 Mar 2026
Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER
Sold on a plan
$256.88K 7,405 at 34.69
7.1%
Planned (10b5-1)
16 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$255.59K 19,060 at 13.41
3.6%
Planned (10b5-1)
16 Mar 2026
Wright Stacy Rochelle Chief Revenue Officer
Sold on a plan
$255.31K 13,750 at 18.57
12.5%
Planned (10b5-1)
16 Mar 2026
Evans Jason Eric Chief Executive Officer
Sold at will
$254.39K 20,400 at 12.47
2.2%
Not planned
16 Mar 2026
Becker Marcus SVP CPO
Sold at will
$250.90K 10,000 at 25.09
26.9%
Not planned
16 Mar 2026
Julian Amanda Director
Sold on a plan
$250.00K 3,473 at 71.98
25.0%
Planned (10b5-1)
16 Mar 2026
Cohlhepp Ryan President and COO
Sold on a plan 2×
$245.71K 12,500 at 19.66
5.9%
Planned (10b5-1)
16 Mar 2026
RAAB MICHAEL President & CEO
Sold on a plan
$243.33K 41,666 at 5.84
2.2%
Planned (10b5-1)
16 Mar 2026
Sold on a plan
$240.32K 8,000 at 30.04
3.4%
Planned (10b5-1)
16 Mar 2026
Hite Fred COO and CFO
Sold at will
$224.13K 12,993 at 17.25
4.5%
Not planned
16 Mar 2026
ROGERS MARK N EVP & General Counsel
Sold on a plan
$222.70K 5,000 at 44.54
11.4%
Planned (10b5-1)
16 Mar 2026
Hoff Brian Joseph Chief Financial Officer
Sold on a plan
$212.16K 11,413 at 18.59
2.2%
Planned (10b5-1)
16 Mar 2026
HELEN SUZANNE L Possible Member of Group · indirect
Sold at will 3×
$206.61K 2,000 at 103.31
3.3%
Not planned
16 Mar 2026
LARSON MATTHEW PAUL Chief Risk Officer
Sold on a plan
$202.50K 11,250 at 18.00
100%
Sold half or more
16 Mar 2026
Misra Amitabh Chief Technology Officer
Sold at will
$200.01K 34,189 at 5.85
3.4%
Not planned
16 Mar 2026
Sold at will
$198.00K 2,000 at 99.00
0.4%
Not planned
16 Mar 2026
Micallef Andrew EVP, Chief Operations Officer
Sold on a plan
$194.58K 1,000 at 194.58
9.1%
Planned (10b5-1)
16 Mar 2026
Rosenbaum Michael George Chief Executive Officer
Sold on a plan
$192.00K 1,200 at 160.00
0.5%
Planned (10b5-1)
16 Mar 2026
Pattabhiraman Arun CHIEF MARKETING OFFICER
Sold at will
$190.13K 32,500 at 5.85
6.3%
Not planned
16 Mar 2026
Wassenaar Yvonne Director
Sold on a plan 4×
$187.40K 1,395 at 134.34
11.1%
Planned (10b5-1)
16 Mar 2026
Slocum Jeffrey Shannon Director, EVP and COO
Sold on a plan
$184.01K 5,441 at 33.82
2.8%
Planned (10b5-1)
16 Mar 2026
Valentine Curtis Chief Financial Officer
Sold at will
$183.31K 2,268 at 80.82
9.8%
Not planned
16 Mar 2026
Ramasastry Saira Director
Sold on a plan
$181.52K 2,000 at 90.76
100%
Sold half or more
16 Mar 2026
Camden Andrew Ross President
Sold on a plan
$178.76K 9,625 at 18.57
2.6%
Planned (10b5-1)
16 Mar 2026
Ghai Rohit Director
Sold on a plan
$176.17K 10,000 at 17.62
26.5%
Planned (10b5-1)
16 Mar 2026
DeVinney Erick Wayne Chief Innovation Officer
Sold at will
$171.46K 5,221 at 32.84
1.9%
Not planned
16 Mar 2026
Carroll Hugh J Director
Sold at will
$168.91K 988 at 170.96
53.3%
Sold half or more
16 Mar 2026
Bartlett Daniel J Executive Vice President
Sold on a plan
$167.33K 1,325 at 126.29
0.2%
Planned (10b5-1)
16 Mar 2026
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$166.50K 3,450 at 48.26
3.6%
Not planned
16 Mar 2026
Caldwell Nick V. Chief Product Officer
Sold at will
$164.77K 42,632 at 3.86
4.6%
Not planned
16 Mar 2026
Sharp Jay Executive Vice President
Sold on a plan 4×
$159.97K 2,000 at 79.99
2.5%
Planned (10b5-1)
16 Mar 2026
Romaine Mark Chief Operating Officer
Sold at will
$158.67K 3,376 at 47.00
2.1%
Not planned
16 Mar 2026
Martell Jorge Garcia Chief Financial Officer
Sold at will
$155.00K 15,000 at 10.33
12.0%
Not planned
16 Mar 2026
CASELLA JOHN W Director
Sold on a plan
$153.07K 1,744 at 87.77
5.4%
Planned (10b5-1)
16 Mar 2026
Patel Naimish Chief Medical Officer
Sold at will
$152.02K 3,150 at 48.26
19.3%
Not planned
16 Mar 2026
Gerritzen Daniel J General Counsel and Secretary
Sold at will
$148.59K 8,614 at 17.25
5.4%
Not planned
16 Mar 2026
Hauser Joseph W Pres. Trauma & Def. Correction
Sold at will
$148.28K 8,596 at 17.25
4.2%
Not planned
16 Mar 2026
Brennan Kieran Senior Vice President
Sold at will
$147.24K 12,000 at 12.27
4.1%
Not planned
16 Mar 2026
Wold Dyan Z. VP, Controller and CAO
Sold on a plan
$146.79K 1,539 at 95.38
24.9%
Planned (10b5-1)
16 Mar 2026
Odle Gregory A President of Scoliosis
Sold at will
$145.47K 8,433 at 17.25
4.3%
Not planned
16 Mar 2026
Mountcastle David EVP & Chief Financial Officer
Sold at will
$141.31K 6,391 at 22.11
2.8%
Not planned
16 Mar 2026
BAUR MICHAEL L CEO, President, BOD Chair
Sold at will
$137.35K 3,827 at 35.89
2.4%
Not planned
16 Mar 2026
Lath Hitesh CHIEF FINANCIAL OFFICER
Sold at will
$136.93K 15,248 at 8.98
6.0%
Not planned
16 Mar 2026
Thompson Jere W III CFO, Executive VP
Sold at will
$136.85K 750 at 182.47
3.6%
Not planned
Showing 27,051–27,100 of 46,041. ← Newer Page 542 of 921 Older →